EDGAR Filing Documents for 0001193125-23-269437

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-23-269437

Filing Date

2023-11-02

Accepted

2023-11-02 16:41:20

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	d553370d424b5.htm	424B5	327521
2	EX-FILING FEES	d553370dexfilingfees.htm	EX-FILING FEES	40851
3	GRAPHIC	g553370g09c84.jpg	GRAPHIC	43536
4	GRAPHIC	g553370g53b65.jpg	GRAPHIC	54231
5	GRAPHIC	g553370g79m67.jpg	GRAPHIC	36717
	Complete submission text file	0001193125-23-269437.txt		555034

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700

Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-268117 | Film No.: 231373117
SIC: 2836 Biological Products, (No Diagnostic Substances)